Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
Power Integrations logo
Power IntegrationsPOWI
1.5%-1.0pp
SSR Mining logo
SSR MiningSSRM
18.7%—
Repligen logo
RepligenRGEN
0.3%-6.3pp
MYR Group logo
MYR GroupMYRG
18.4%+13.4pp

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$3.79B+21.9%

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0×0.0×
Current ratio18.6×-3.9×

Where this comes from

Calculated from Crinetics Pharmaceuticals’s reported figures.

$47.9Mtotal debt+$1.3Btotal stockholders equity−$115.1Mcash and equivalents=$1.21B

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's invested capital?
Crinetics Pharmaceuticals (CRNX) reported invested capital of $1.21B in Q1 2026.
How has Crinetics Pharmaceuticals's invested capital changed year-over-year?
Crinetics Pharmaceuticals's invested capital increased by 0.4% year-over-year, from $1.21B to $1.21B.
What is the long-term trend for Crinetics Pharmaceuticals's invested capital?
Over 5 years (2020 to 2025), Crinetics Pharmaceuticals's invested capital has grown at a 63.3% compound annual growth rate (CAGR), from $80.68M to $938.29M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).